BioSpace News Archive

Compounding Pharmacy Market to Experience Significant Growth by 2025

Wilmington, Delaware, United States, Transparency Market Research Inc.: Compounding is the science of combining and preparing personalized medicines for patients.

August 1, 2022
·
6 min read
Agrigenomics Market: Rise in Demand for Crop and Livestock to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Agrigenomics is defined as the study of the genetic makeup of crops and livestock and how genes influence the produce.

August 1, 2022
·
6 min read
Neuroprosthetics Market: Increasing Incidence of Neurological Disorders and Nerve Injuries to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global neuroprosthetics market is estimated to rise at a healthy rate from 2021 to 2031.

August 1, 2022
·
6 min read
Policy

Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS

Pharming Group N.V. announces that the European Medicines Agency’s Committee for Medicinal Products for Human Use has granted an accelerated assessment for the Marketing Authorisation Application for leniolisib.

August 1, 2022
·
7 min read
Business

Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer

Vico Therapeutics B.V., a neurology-focused genetic medicine company, announced the appointment of Micah Mackison as Chief Executive Officer.

August 1, 2022
·
2 min read
Pharm Country

HUTCHMED Initiates a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China

HUTCHMED Limited announces that it has initiated a bridging study of tazemetostat in China.

August 1, 2022
·
7 min read
Policy

Eccogene Announces US IND Approval for THRβ agonist ECC4703

Eccogene announced that the U.S. Food and Drug Administration has approved the investigational new drug application to commence Phase I trial of its thyroid hormone receptor agonist ECC4703 in U.S.

August 1, 2022
·
2 min read
Drug Development

NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of Large Surface Area Microparticle Docetaxel in High-Risk Non-Muscle Invasive Bladder Cancer

NanOlogy LLC, a clinical-stage interventional oncology drug company, announced that results from a clinical trial of Large Surface Area Microparticle Docetaxel in High-Risk Non-Muscle Invasive Bladder Cancer have been published in The Journal of Urology®.

August 1, 2022
·
5 min read
Business

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2022

Amphastar Pharmaceuticals, Inc. announced that the Company will release results for its second quarter of 2022 ended June 30, 2022, after the market closes on Monday, August 8, 2022, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.

August 1, 2022
·
2 min read
Business

Cerevel Therapeutics Reports Second Quarter 2022 Financial Results and Business Updates

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, reported financial results for the quarter ended June 30, 2022 and provided key pipeline and business updates.

August 1, 2022
·
13 min read